TRAI — Trilogy AI Income Statement
0.000.00%
Last trade - 00:00- CA$3.92m
- CA$3.92m
Annual income statement for Trilogy AI, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.146 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0.083 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.438 | 3.82 | 0.845 | 1.73 | 0.575 |
| Operating Profit | -0.438 | -3.68 | -0.845 | -1.73 | -0.575 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.433 | -3.66 | -0.861 | -1.74 | -0.575 |
| Net Income After Taxes | -0.433 | -3.66 | -0.861 | -1.74 | -0.575 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.433 | -3.66 | -1.32 | -2.51 | -0.664 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.433 | -3.66 | -1.32 | -2.51 | -0.664 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.034 | -0.287 | -0.077 | -0.13 | -0.041 |
| Dividends per Share |